Daniel E. Dunn

1.5k total citations
27 papers, 1.1k citations indexed

About

Daniel E. Dunn is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Daniel E. Dunn has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 8 papers in Hematology and 6 papers in Oncology. Recurrent topics in Daniel E. Dunn's work include Immune Cell Function and Interaction (11 papers), Complement system in diseases (9 papers) and T-cell and B-cell Immunology (8 papers). Daniel E. Dunn is often cited by papers focused on Immune Cell Function and Interaction (11 papers), Complement system in diseases (9 papers) and T-cell and B-cell Immunology (8 papers). Daniel E. Dunn collaborates with scholars based in United States, France and Japan. Daniel E. Dunn's co-authors include Neal S. Young, Jaroslaw P. Maciejewski, Stephen J. Rosenfeld, Frank Weichold, Martha Kirby, Shoichi Nagakura, F W Fitch, Marie Malissen, Leroy Hood and Najet Rebaï and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Daniel E. Dunn

27 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel E. Dunn United States 17 771 374 192 173 169 27 1.1k
J L Preud'homme France 16 275 0.4× 115 0.3× 237 1.2× 73 0.4× 70 0.4× 39 700
Toni B. Simonis United States 19 938 1.2× 295 0.8× 279 1.5× 33 0.2× 350 2.1× 27 1.3k
Suzanne Skoda‐Smith United States 13 579 0.8× 172 0.5× 394 2.1× 27 0.2× 137 0.8× 26 1.0k
A. Bohbot France 16 647 0.8× 215 0.6× 362 1.9× 18 0.1× 141 0.8× 40 1.1k
Paul Chien United States 19 675 0.9× 417 1.1× 565 2.9× 33 0.2× 85 0.5× 40 1.5k
K L Simpson United Kingdom 15 498 0.6× 186 0.5× 361 1.9× 22 0.1× 134 0.8× 16 1.1k
C Bindon United Kingdom 12 727 0.9× 140 0.4× 409 2.1× 22 0.1× 219 1.3× 15 1.3k
Frances Santiago‐Schwarz United States 20 1.1k 1.4× 133 0.4× 312 1.6× 25 0.1× 219 1.3× 44 1.4k
Paul Guglielmi France 14 415 0.5× 116 0.3× 278 1.4× 28 0.2× 87 0.5× 23 758
R. J. Winchester United States 18 1.1k 1.4× 493 1.3× 415 2.2× 20 0.1× 123 0.7× 24 1.9k

Countries citing papers authored by Daniel E. Dunn

Since Specialization
Citations

This map shows the geographic impact of Daniel E. Dunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Dunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Dunn more than expected).

Fields of papers citing papers by Daniel E. Dunn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel E. Dunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Dunn. The network helps show where Daniel E. Dunn may publish in the future.

Co-authorship network of co-authors of Daniel E. Dunn

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel E. Dunn. A scholar is included among the top collaborators of Daniel E. Dunn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel E. Dunn. Daniel E. Dunn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nagakura, Shoichi, Daniel E. Dunn, J Nishimura, et al.. (2002). Decreased susceptibility of leukemic cells with PIG-Amutation to natural killer cells in vitro. Blood. 100(3). 1031–1037. 41 indexed citations
2.
Maciejewski, Jaroslaw P., Candido E. Rivera, Hoon Kook, Daniel E. Dunn, & Neal S. Young. (2001). Relationship between bone marrow failure syndromes and the presence of glycophosphatidyl inositol‐anchored protein‐deficient clones. British Journal of Haematology. 115(4). 1015–1022. 95 indexed citations
3.
Chen, Rui, Shanmugam Nagarajan, Uma Maheshwari, et al.. (2000). Impaired growth and elevated Fas receptor expression in PIGA+ stem cells in primary paroxysmal nocturnal hemoglobinuria. Journal of Clinical Investigation. 106(5). 689–696. 44 indexed citations
4.
Tisdale, John F., Daniel E. Dunn, & Jaroslaw Maciejewski. (2000). Cyclophosphamide and other new agents for the treatment of severe aplastic anemia. Seminars in Hematology. 37(1). 102–109. 19 indexed citations
5.
Tisdale, John F., Daniel E. Dunn, Nancy L. Geller, et al.. (2000). High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial. The Lancet. 356(9241). 1554–1559. 99 indexed citations
6.
Dunn, Daniel E., et al.. (1999). Research directions in paroxysmal nocturnal hemoglobinuria. Immunology Today. 20(4). 168–171. 12 indexed citations
7.
Dunn, Daniel E., Piernicola Boccuni, Shoichi Nagakura, et al.. (1999). Paroxysmal Nocturnal Hemoglobinuria Cells in Patients with Bone Marrow Failure Syndromes. Annals of Internal Medicine. 131(6). 401–408. 196 indexed citations
8.
Zella, Davide, Jennifer M. Burns, Fabio Romerio, et al.. (1998). Interferon-γ Increases Expression of Chemokine Receptors CCR1, CCR3, and CCR5, But Not CXCR4 in Monocytoid U937 Cells. Blood. 91(12). 4444–4450. 18 indexed citations
9.
Weichold, Frank, Davide Zella, Jaroslaw P. Maciejewski, et al.. (1998). Neither Human Immunodeficiency Virus-1 (HIV-1) nor HIV-2 Infects Most-Primitive Human Hematopoietic Stem Cells as Assessed in Long-Term Bone Marrow Cultures. Blood. 91(3). 907–915. 55 indexed citations
10.
Wang, Jianxiang, Takemi Otsuki, Hagop Youssoufian, et al.. (1998). Overexpression of the fanconi anemia group C gene (FAC) protects hematopoietic progenitors from death induced by Fas-mediated apoptosis.. PubMed. 58(16). 3538–41. 40 indexed citations
11.
Weichold, Frank, Davide Zella, Jaroslaw P. Maciejewski, et al.. (1998). Neither Human Immunodeficiency Virus-1 (HIV-1) nor HIV-2 Infects Most-Primitive Human Hematopoietic Stem Cells as Assessed in Long-Term Bone Marrow Cultures. Blood. 91(3). 907–915. 3 indexed citations
12.
Hoshino, Taizo, Yin Jiang, Daniel E. Dunn, et al.. (1998). Transfection of interleukin-12 cDNAs into tumor cells induces cytotoxic immune responses against native tumor: implications for tumor vaccination.. PubMed. 5(3). 150–7. 9 indexed citations
13.
Devetten, Marcel P., Vicki Ling, Frank Weichold, et al.. (1997). Paroxysmal nocturnal hemoglobinuria: new insights from murine Pig-a-deficient hematopoiesis.. PubMed. 109(2). 99–110. 3 indexed citations
14.
15.
Dunn, Daniel E., Jianliang Jin, D W Lancki, & Frank W. Fitch. (1989). An alternative pathway of induction of lymphokine production by T lymphocyte clones.. The Journal of Immunology. 142(11). 3847–3856. 13 indexed citations
16.
Yokoyama, Akihito, Brian D. Evavold, Daniel E. Dunn, & J Quintáns. (1989). Production of IL-2 and IFN by TH2 clones. Immunology Letters. 21(2). 119–125. 20 indexed citations
17.
Malissen, Marie, Jeannine Trucy, François Letourneur, et al.. (1988). A T cell clone expresses two T cell receptor α genes but uses one αβ heterodimer for allorecognition and self MHC-restricted antigen recognition. Cell. 55(1). 49–59. 178 indexed citations
18.
Ford, Henri R., David S. Fryd, D. M. Canafax, et al.. (1988). Adjunctive azathioprine and antilymphocyte serum immunosuppression with cyclosporine.. PubMed. 20(3 Suppl 3). 8–12. 2 indexed citations
19.
Otten, Gillis R., et al.. (1986). PMA alone induces proliferation of some murine T cell clones but not others.. The Journal of Immunology. 137(9). 2755–2760. 26 indexed citations
20.
Herold, Kevan C., D W Lancki, Daniel E. Dunn, Ken‐ichi Arai, & Frank W. Fitch. (1986). Activation of lymphokine genes during stimulation of cloned T cells. European Journal of Immunology. 16(12). 1533–1538. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J L Preud'homme Breakdown of academic impact, for papers by Toni B. Simonis Breakdown of academic impact, for papers by Suzanne Skoda‐Smith Breakdown of academic impact, for papers by A. Bohbot Breakdown of academic impact, for papers by Paul Chien Breakdown of academic impact, for papers by K L Simpson Breakdown of academic impact, for papers by C Bindon Breakdown of academic impact, for papers by Frances Santiago‐Schwarz Breakdown of academic impact, for papers by Paul Guglielmi Breakdown of academic impact, for papers by R. J. Winchester
Rankless by CCL
2026